baber/WOPTO huggingface dataset:
Patent JP-3877038-B2 (JP)
IPC: B05D1/30
Filed: 1999-11-10
Granted: 2007-02-07
Abstract: PROBLEM TO BE SOLVED: To simply and rapidly realize the quantitative discharge of a liquid material. SOLUTION: In a method for pressurizing a liquid material in a syringe and applying a specified amount of the liquid material from a nozzle communicating with the syringe to draw an image, parameters relative to the shape of a drawn image of the applied liquid material, preferably dots or lines, preferably one parameter selected from a group of a section area, an application width, an application height and an application diameter, are measured. Further, the measurements are adjusted so as to allow them to fall within the acceptable value range of the parameters relative to a desired shape of a specified drawn image, and preferably the pressurizing force is adjusted. Thus the method for drawing an image by applying the liquid is performed. The liquid applying device comprises a syringe for storing the liquid material, a pressure regulating means which pressurizes or reduces the pressure of the liquid material in the syringe, a nozzle which communicates with the syringe and has a discharge aperture at the tip, a moving means for moving the nozzle relatively with a work, a measuring means which measures the parameters relative to the shape of the applied liquid material, an arithmetic means which calculates an appropriate pressure upon a signal from the measuring means and preferably a shift pressure input means for inputting a shift pressure value.
Patent JP-3025271-B2 (JP)
IPC: C07K19/00
Filed: 1986-12-02
Granted: 2000-03-27
Abstract: Methods are provided for detecting and determining the amount in a sample of an antigenic determinant from an antigen receptor derived and released from a T cell or NK cell. Methods are also provided for detecting and determining the amount in a sample of an antigenic determinant from a complex of at least a portion of an antigen receptor derived from and released from a T cell or NK cell and a protein complex. These methods form the bases for methods of diagnosing and monitoring in a subject a disease characterized by the presence or an amount different from a normal subject of one of these antigenic determinants in a body fluid. A soluble antigen receptor or complex thereof derived from a T cell or a NK cell but free of such T cell or NK cell is also provided.
Patent JP-3255918-B2 (JP)
IPC: B01D53/18
Filed: 1992-03-30
Granted: 2002-02-12
Abstract: A vapor-liquid distribution method and apparatus utilize a cap assembly for attachment over an opening in a deck tray of a gas-liquid contact apparatus (e.g., catalytic reactor). The cap assembly comprises a riser located over the opening in the deck tray, and providing fluid communication from an upper surface to a lower surface of the deck tray. A cap encompasses an upwardly extending end of the riser. A key feature of the assembly is the provision of a dispersion plate in a lower end of the riser which provides a flow restriction for two phase fluids flowing through the riser to produce a mist flow of the two phases. Preferably, the dispersion plate has a plurality of openings therethrough, at least the outer openings being provided with tabs to disperse the mist flow radially outward.
Patent JP-H0786501-B2 (JP)
IPC: B01J19/08
Filed: 1990-01-16
Abstract: PCT No. PCT/US90/00184 Sec. 371 Date Jun. 20, 1991 Sec. 102(e) Date Jun. 20, 1991 PCT Filed Jan. 16, 1990.Electrophoretic resolving gel compositions, discontinuous stacking gel systems containing these and other resolving gel compositions, and kits for preparing such gel systems, comprising one or more polysaccharide hydrogels of which agarose is typical wherein at least one of the gels in the resolving gel composition has been derivatized and at least one of the gels in the resolving gel composition has been depolymerized sufficiently to reduce its casting-effective viscosity.
Patent JP-2672137-B2 (JP)
IPC: A61F13/04
Filed: 1988-04-08
Granted: 1997-11-05
Abstract: PCT No. PCT/GB88/00278 Sec. 371 Date Oct. 11, 1989 Sec. 102(e) Date Oct. 11, 1989 PCT Filed Apr. 8, 1988 PCT Pub. No. WO88/07847 PCT Pub. Date Oct. 20, 1988.A substrate suitable for use in a water hardenable orthopaedic splinting bandage is formed from a knitted fabric in which the yarn running along the length of the substrate is from a heat shrinkable yarn so that after heat treatment the substrate is stretchable in the lengthwise direction. The heat shrinkable yarn is suitably a polyester or polyamide and the non-heat shrinkable yarn is suitably a different polyester or polypropylene. Preferably the substrate has a lengthwise extension of not less than 5% and not more than 30%. A water hardenable orthopaedic bandage in which the substrate is impregnated with a water curable resin particularly an isocyanate-containing resin is also described.
Patent JP-3001969-B2 (JP)
IPC: C07K16/00
Filed: 1990-01-17
Granted: 2000-01-24
Abstract: Monoclonal antibodies that bind to an apparent conformational epitope associated with recombinant or native dimeric M-CSF with concomitant neutralization of biological activity, which monoclonal antibodies are substantially unreactive with biologically inactive forms of M-CSF including monomeric and chemically derivatized dimeric M-CSF, are described. Methods of using the antibodies in assays for detection of dimeric M-CSF are also described.
Patent JP-2677403-B2 (JP)
IPC: C07C309/66
Filed: 1988-03-31
Granted: 1997-11-17
Abstract: This invention relates to novel methods for facilitating the enzymatic resolution of racemic mixtures of esters, which are derivatized with groups which enhance the esters' aqueous solubility, in an extractive member reactor where the enzyme is placed alternatively either (1) in the aqueous phase, (2) in association with the membrane, or (3) in the aqueous phase and in association with the membrane, wherein the aqueous ester phase is contacted with one side of the membrane, and where an organic extractive phase is contacted with the other side of the membrane, wherein the extractive phase serves to remove the resolving reaction product. Of particular significance regarding this invention is its use of water soluble esters that are derivatized with groups which enhance their aqueous solubility and their reactivity with enzymatic resolving methods which are mediated in an aqueous environment. Novel methods were utilized to prepare these esters, for use in this invention's methods for enzymatically resolving the racemic mixtures of the esters, to produce the separate chiral isomers of the racemic mixture. The importance of the resolution of the separate chiral isomers of the racemic mixtures resides in the isolation of the isomers which frequently have different biological activities.
Patent JP-H0690134-B2 (JP)
IPC: G01N21/64
Filed: 1985-10-22
Abstract: PCT No. PCT/SE85/00408 Sec. 371 Date Jun. 23, 1986 Sec. 102(e) Date Jun. 23, 1986 PCT Filed Oct. 22, 1985 PCT Pub. No. WO86/02730 PCT Pub. Date May 9, 1986.A fluorescence imaging system. A light source irradiates an object to be viewed. The irradiated object is imaged through a beam-splitting system to form individual displaced images of the object. The displaced images are further filtered in a filter having a frequency passband different from the other filters. The filtered images are imaged on a detector. The same image point of each image is detected and converted into an electrical signal. A circuit means is provided to receive the signals of each common image point, and weight the same. The weighted signal represents an image point pixel. The weighted pixels are displayed as an image of the object having improved contrast.
Patent JP-3311346-B2 (JP)
IPC: A61K38/095
Filed: 1991-02-28
Granted: 2002-08-05
Abstract: A chimeric toxin comprising protein fragments joined together by peptide bonds, the chimeric toxin comprising, in sequential order, beginning at the amino terminal end of the chimeric toxin, (a) the enzymatically active Fragment A of diphtheria toxin, (b) a first fragment including the cleavage domain 11 adjacent the Fragment A of diphtheria toxin, (c) a second fragment comprising at least a portion of the hydrophobic transmembrane region of Fragment B of diphtheria toxin, the second fragment having a deletion of at least 50 diphtheria toxin amino acid residues, the deletion being C-terminal to the portion of the transmembrane region, and the second fragment not including domain 12, and (d) a third fragment comprising a portion of a cell-specific polypeptide ligand, the portion including at least a portion of the binding domain of the polypeptide ligand, the portion of the binding domain being effective to cause the chimeric toxin to bind selectively to a predetermined class of cells to be attacked by the enzymatically active Fragment A.
Patent JP-H064487-B2 (JP)
IPC: C04B35/628
Filed: 1989-08-03
Abstract: PCT No. PCT/AT89/00069 Sec. 371 Date Apr. 5, 1990 Sec. 102(e) Date Apr. 5, 1990 PCT Filed Aug. 3, 1989 PCT Pub. No. WO90/01460 PCT Pub. Date Feb. 22, 1990.A magnesium oxide in fine powder form, which can be used to manufacture high-density ceramics, has an MgO content greater than 95 wt. %, preferably greater than 98 wt. %, a particle size less than 15  mu m, and a BET specific surface area less than 20 m2/g. The statistical mean of the particle shape factor of the primary particles lies between 1 and 1.5. The particles are coated with a hydrophobic, surface-active substance.
Patent JP-2949508-B2 (JP)
IPC: A61P43/00
Filed: 1989-10-13
Granted: 1999-09-13
Abstract: A novel compound and method for making and using compositions containing S-(-)-3-morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5 thiadiazole hemihydrate useful for administration to a subject particularly for topical administration as a pharmaceutical agent for treating known conditions and disorder.
Patent JP-3406315-B2 (JP)
IPC: A61N1/30
Filed: 1992-12-11
Granted: 2003-05-12
Abstract: Apparatus (11) for delivery of a medicament, drug or other therapeutic agent transdermally to a body by iontophoresis is provided. The apparatus (11) provides a means (13) for measuring and displaying the cumulative amount of the medicament delivered to the body by monitoring the amount of a metal, initially present at the anode (45), that is transferred to the cathode (41) in a subsidiary electrolyte cell (47) through which the drive current for the apparatus (11) passes. Optionally, the apparatus also provides a plurality of light emitting devices (63-1) that display a measure of the cumulative amount of medicament delivered, by use of visually distinguishable light colors or by use of binary encoding in the light display.
Patent JP-3254486-B2 (JP)
IPC: C07C333/06
Filed: 1993-11-01
Granted: 2002-02-04
Abstract: Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty restenosis, coronary artery diseases, and angina, as well as noncardiovascular inflammatory diseases that are mediated by VCAM-1.
Patent JP-3122127-B2 (JP)
IPC: A61K38/55
Filed: 1990-08-17
Granted: 2001-01-09
Abstract: PCT No. PCT/DK90/00212 Sec. 371 Date Jan. 27, 1992 Sec. 102(e) Date Jan. 27, 1992 PCT Filed Aug. 17, 1990 PCT Pub. No. WO91/02753 PCT Pub. Date Mar. 7, 1991.Novel extrinsic pathway inhibitors (EPI) are provided wherein one or more of the amino acid residues of native EPI have been deleted. A preferred group of the novel EPI analogues have no or a low heparin binding capacity. The novel EPI analogues can be used for the treatment of patients having coagulation disorders or cancer.
Patent JP-2955362-B2 (JP)
IPC: E01C13/08
Filed: 1991-10-15
Granted: 1999-10-04
Abstract: PCT No. PCT/NL91/00202 Sec. 371 Date Feb. 8, 1993 Sec. 102(e) Date Feb. 8, 1993 PCT Filed Oct. 15, 1991 PCT Pub. No. WO92/07142 PCT Pub. Date Apr. 30, 1992The invention relates to a field containing artificial grass consisting of a substructure and a top layer provided thereon, wherein the top layer is a nutrient medium (50) which contains regularly spaced fibers (1) which, when seen in the longitudinal direction of the fiber, extend further into the ground than above the ground, with natural grass (2) seeded between the fibers in a nutrient medium (5) on the substructure (3). The invention also relates to artificial fibers to be used with a field containing artificial grass wherein the fibers have a length of 20 60 cm. The invention further relates to a device for inserting artificial fibers into the ground, said device consisting of one or more planting pins (25), which are disposed perpendicularly to a frame (40), one or more tubes (20) being placed in a sliding frame (41) for supplying the fibers (30) to a location under the planting pin (25).
Patent JP-2803906-B2 (JP)
IPC: H05K5/02
Filed: 1994-02-21
Granted: 1998-09-24
Abstract: PCT No. PCT/EP94/00496 Sec. 371 Date Sep. 7, 1995 Sec. 102(e) Date Sep. 7, 1995 PCT Filed Feb. 21, 1994 PCT Pub. No. WO94/19850 PCT Pub. Date Sep. 1, 1994The invention relates to a cabinet for receiving electrical and electronic equipment and subassemblies with facing parts, which comprises a frame of vertical, horizontal and transverse sectional bars interconnected by means of corner connectors. In order to obtain a particularly stable and secure cabinet, which also allows an extremely efficient manufacture and assembly, each corner connector is provided with through holes and guide elements constructed in the space coordinate direction for frontal reception and for the easy, reliable fixing of a sectional bar. In addition, each corner connector has a reception area for fixing a base. The base corner parts are preferably made from a one-piece, metallic flat material.
Patent JP-3521913-B2 (JP)
IPC: G01N33/483
Filed: 1995-01-13
Granted: 2004-04-26
Abstract: A method of diagnosing severity of periodontal disease or peri-implant disease in a human patient, involving a) obtaining a sample of tissue or gingival crevicular or other fluid from the mouth of said patient, or a blood or urine sample from the patient, and b) measuring a pyridinoline crosslinked compound in the sample as a measure of severity of disease.
Patent JP-4067058-B2 (JP)
IPC: C07K14/475
Filed: 1996-03-07
Granted: 2008-03-26
Abstract: This invention relates to a PEG-modified HGF (Hepatocyte Growth Factor), namely HGF modified by polyethylene glycol. The PEG-modified HGF of the invention has a prolonged clearance in vivo, effectively exhibits its physiological activity for a long period of time, and has the same physiological activity as HGF, which makes it possible to reduce the dose and relieve the side effects of the same.
Patent JP-3851655-B2 (JP)
IPC: H01F1/26
Filed: 1995-04-24
Granted: 2006-11-29
Abstract: PCT No. PCT/SE95/00445 Sec. 371 Date Oct. 11, 1996 Sec. 102(e) Date Oct. 11, 1996 PCT Filed Apr. 24, 1995 PCT Pub. No. WO95/29490 PCT Pub. Date Nov. 2, 1995The invention concerns a method of compacting and heat-treating iron powders in order to obtain magnetic core components having improved soft magnetic properties. The iron powder consists of fine particles which are insulated by a thin layer having a low phosphorous content. According to the invention, the compacted iron powder is subjected to heat treatment at a temperature between 350 DEG  and 550 DEG  C.
Patent JP-3564575-B2 (JP)
IPC: G01N29/32
Filed: 1997-03-19
Granted: 2004-09-15
Abstract: This invention relates to a method of determining the concentration of each component of a ternary mixture essentially consisting of sulfuric acid, hydrogen fluoride, and water, which comprises measuring at least one set of three physical quantities, viz. (1) temperature, (2) ultrasound propagation velocity, and (3) electrical conductivity or viscosity, of said ternary mixture and converting measured values to the concentration of the particular component with reference to separately pre-constructed calibration curves representing the relationships of the concentrations of respective components of a ternary mixture of sulfuric acid, hydrogen fluoride, and water to said three physical quantities. This invention relates to the process for continuous production of hydrogen fluoride using the method of the invention for determining the component concentration, particularly the concentration of water, of a ternary mixture, too. <IMAGE>
Patent JP-4295826-B2 (JP)
IPC: G01N33/53
Filed: 1997-03-25
Granted: 2009-07-15
Abstract: The present invention relates to monoclonal antibodies that bind to the extracellular domain of prostate specific membrane antigen (PSMA), hybridoma cell lines producing the antibodies, and methods of using such antibodies for diagnosis and treatment of cancer. In particular, it relates to three monoclonal antibodies reactive with PSMA expressed on the cell surface and in sera of prostate cancer patients. Additionally, the present invention relates to a novel protein variant (PSM') of PSMA detected by an antibody of the invention. The hydrolase activity of PSMA and PSM' allows the use of an immunoenzymatic assay for their detection.
Patent JP-3872109-B2 (JP)
IPC: A61F13/49
Filed: 1997-03-27
Granted: 2007-01-24
Abstract: Absorbent article comprising an absorbent core with a crotch region and at least one waist region, whereby said crotch region has a lower ultimate fluid storage capability than said at least one waist region. The article further has an improved fluid handling performance such as an acquisition rate of at least 0.6 ml in the fourth gush.
Patent JP-3821488-B2 (JP)
IPC: B29C67/20
Filed: 1997-05-07
Granted: 2006-09-13
Abstract: Layered composite materials adapted to be formed into predetermined shaped components disposed for contact with moisture and body fluids having a cover layer for contact with the moisture and body fluids and a foam layer including one or more sorbents in a hydrophilic polyurethane foam matrix, wherein the foam layer is bonded to the cover layer so that moisture and body fluids in contact with the cover layer are transferred through the cover layer to the foam layer. The foam layer is established by combining an aqueous mixture including the sorbent in a predetermined ratio with the hydrophilic polyurethane. The foam layer may include other active ingredients such as odor absorption and bactericidal components, thermal phase change components and finely ground rubber tire materials to vary the characteristics of the composite material. Additionally, citric acid and surfactant compounds may be used to increase the concentration of the sorbent in the aqueous mixture and maintain the pumping fluidity of the aqueous mixture. Methods for making the layered composite materials are also described.
Patent PL-157798-B2 (PL)
Title: Method of dehumidifying masonry saturated with moisture
IPC: C08L/
Filed: 1988-03-15
Abstract: The invention concerns a method of damp wall drying by creating hydrophobic membrane, consisting in execution of a series of holes in wall and driving under pressure into those holes hydrophobic agents including methyl silicone resin, ethyl alcohol and organic solvent, characterised in that at the first stage into holes in wall is forced insulating agent in form of sodium water-glass mixed with water in proportion 1:1 to 1:0.5 with addition of sodium fluosilicate in amount 5-15 % per mass in proportion to amount of water-glass, next is introduced hydrophobic agent being a composition of in percent per mass: methyl silicone resin 10-15, ethyl alcohol 50-60% and organic solvent 30-35%.
Patent PL-160179-B2 (PL)
Title: Gas burner
IPC: F23D14/62
Filed: 1989-08-08
Abstract: A gas burner fitted with gas and air pipes, a disc and a combustion chamber, consisting in that at the end of the gas pipe (2), a disc (4) is located with a combustion chamber (5), a gas channel (6) and air channel (7), whereas those channels are tipped with cylindrical aperures (8), whereas the disc (4) includes air holes (9) and air grooves (10).<IMAGE>
Patent ES-2279712-B2 (ES)
Title: Aireador de vehiculo.
Inventor: MANDALUNIZ BILBAO JOSEBA
IPC: B60H1/34
Filed: 2005-12-22
Granted: 2008-08-16
Abstract: Aireador de vehículo. Aireador (1) de vehículo, que comprende unas lamas (2) y/o una tapa (4) de accionamiento automático, siendo el medio de accionamiento de las lamas (2) y/o la tapa (4) preferentemente un motor o un actuador basado en materiales SMA (13, 15), éste último funcionando en combinación con un muelle convencional (14, 16). El aireador (1) puede presentar un diseño sencillo, únicamente provisto de lamas (2) de accionamiento automático y movimiento continuo para conseguir una aireación indirecta, con o sin tapa (4). También puede presentar diseños más complejos provistos no sólo de lamas (2) de accionamiento automático y aireación indirecta sino también de lamas convencionales (5) para aireación directa, con o sin tapa (4).
Patent AU-2001227940-B2 (AU)
Title: Disruption of plant material to readily hydrolyzable cellulosic particles
Inventor: HATA SEIJI
IPC: C08H8/00
Filed: 2001-01-16
Granted: 2007-09-06
Abstract: A process for disrupting cellulosic biomass into a readily hydrolyzable cellulose powder consisting of gradually hydrating the paracrystalline cellulose while applying mechanical forces to strip away cellulose polymer chains as soon as the hydration negates the hydrogen bonds between adjacent polymer chains. A preferred way of attaining disruption is to rapidly agitate particles of cellulosic biomass in a container to form a gaseous suspension of the particles. The temperature of the suspended particles is raised and water is gradually introduced as a fine spray or as a vapor. The cellulosis particles become increasingly hydrated without the obvious presence of liquid water. The particles can be periodically dehydrated by increasing the rate of mixing while stopping the addition of water while venting water vapor to the atmosphere. The ultimate product is an extremely fine cellulosic power that is extremely susceptible to either chemical hydrolysis or enzymatic digestion to yield simple sugars.
Patent AU-2001262661-B2 (AU)
Title: A cleansing device for wc pans
Inventor: PERAZZO LIVIA
IPC: C11D1/90
Filed: 2001-05-17
Granted: 2005-07-28
Abstract: The cleansing device for WC pans comprises a transparent, solid bar (10) preferably formed by a composition comprising at least: dibenzylidene sorbitol at a concentration of between 1 and 10%, polar solvent having a dissolving power with respect to dibenzylidene sorbitol at a concentration of between 5 and 90%, and surfactant at a concentration of between 1 and 60%. <IMAGE>
Patent AU-2002243757-B2 (AU)
Title: Mask composition
Inventor: TRIGG DAVID LEIGH
IPC: A61K8/67
Filed: 2002-02-01
Granted: 2005-09-22
Abstract: Disclosed is a mask composition comprising: (1) a water insoluble substrate; and (2) a liquid composition comprising: (a) a skin tone changing agent selected from the group consisting of skin tone changing pigments, reflective particulate material, and mixtures thereof, wherein the skin tone changing agent has a particle size of at least about 100nm; (b)a water-soluble thickening agent which provides the liquid composition a viscosity of from about 1000 mPa<s to about 600,000 mPa?s; and (c) an aqueous carrier.
Patent AU-2002323217-B2 (AU)
Title: Treatment of muscular dystrophies and related disorders
Inventor: RAFFII MICHAEL
IPC: A61K38/17
Filed: 2002-08-15
Granted: 2008-04-10
Abstract: The invention provides, among other aspects, compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan; diseases or conditions associated with an abnormal level or activity of collagen VI; disorders associated with an unstable cytoplasmic membrane, due, e.g., to an unstable dystrophin associated protein complex (DAPC); and disorders associated with abnormal synapses or neuromuscular junctions, including those resulting from an abnormal MuSK activation or acetylcholine receptor (AChR) aggregation.